Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II
Journal of Translational Internal Medicine · 02.11.2026 · 14 (5) · 842-845
DOI: 10.1515/jtim-2026-0069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 24.08.2026. Verfasst von Shuang Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Genetics, Basic Medical College, Jinzhou Medical University, Jinzhou, Liaoning Province, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cell Biology and Genetics, Basic Medical College, Jinzhou Medical University, Jinzhou, Liaoning Province, China.
- Liaoning Province Key Laboratory of Human Phenome Research, Jinzhou Medical University, Jinzhou, Liaoning Province, China.
- School of Public Health, Shenyang Medical College, Shenyang, Liaoning Province, China.
- Liaoning Medical Functional Food Professional Technology Innovation Center, Shenyang Medical College, Shenyang, Liaoning Province, China.
Zitieren
APA
Tian, S., Liu, C., & Wu, J. (2026). Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II. Journal of Translational Internal Medicine, 14(5), 842-845. https://doi.org/10.1515/jtim-2026-0069
Vancouver
Tian S, Liu C, Wu J. Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II. Journal of Translational Internal Medicine. 2026;14(5):842-845. doi:10.1515/jtim-2026-0069
BibTeX
@article{Tian2026,
author = {Tian, Shuang and Liu, Chao and Wu, Jie},
title = {Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II},
journal = {Journal of Translational Internal Medicine},
year = {2026},
volume = {14},
number = {5},
pages = {842--845},
doi = {10.1515/jtim-2026-0069}
}
EUVIMED